Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

Hey dh,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
lumpy9200 Member Profile
Member Level 
Followed By 19
Posts 1,424
Boards Moderated 1
Alias Born 05/21/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2020 7:02:25 AM
Zynerba Pharmaceuticals Announces that Enrollment is Nearing Completion in Pivotal CONNECT-FX Trial in Fragile X Syndrome GlobeNewswire Inc. - 1/13/2020 6:50:10 AM
Zynerba Pharmaceuticals Announces Achievement of Enrollment Target in Phase 2 Trial of Zygel™ in Autism Spectrum Disorder GlobeNewswire Inc. - 1/13/2020 6:45:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 12/2/2019 1:38:19 PM
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Fragile X Syndrome with Transdermal Cannabidiol GlobeNewswire Inc. - 11/12/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 8:17:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 7:01:31 AM
Zynerba Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights GlobeNewswire Inc. - 11/6/2019 6:45:00 AM
Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Zynerba Pharmace... PR Newswire (US) - 10/28/2019 10:42:00 AM
Zynerba Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference GlobeNewswire Inc. - 10/25/2019 1:45:05 PM
Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Zynerba Pharmace... Business Wire - 10/25/2019 12:06:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 4:06:28 PM
Zynerba Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 11:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2019 7:05:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2019 7:14:48 AM
Zynerba Pharmaceuticals Announces Positive Top Line Data from BELIEVE 1 Open Label Phase 2 Study of Zygel™ in Developmental... GlobeNewswire Inc. - 9/18/2019 6:30:00 AM
New Caregiver-Reported Data Further Validate the Use of the Aberrant Behavior Checklist Community: FXS Specific (ABC-CFXS) Su... GlobeNewswire Inc. - 9/5/2019 7:00:00 AM
Autism Spectrum Disorder, Fragile X Syndrome, and 22q11.2 Deletion Syndrome Share a Constellation of Sociobehavioral Symptoms... GlobeNewswire Inc. - 9/5/2019 7:00:00 AM
Zynerba Pharmaceuticals to Present at Two Upcoming Conferences GlobeNewswire Inc. - 9/3/2019 11:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/30/2019 4:27:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/30/2019 4:02:14 PM
Zynerba Pharmaceuticals Announces Poster Presentations at the 22nd Society for the Study of Behavioural Phenotypes (SSBP) Sym... GlobeNewswire Inc. - 8/29/2019 7:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/14/2019 6:00:55 AM
Zynerba Pharmaceuticals Announces Publication of Zygel™ (ZYN002) 12-week Open Label Fragile X Syndrome Data in the Journal ... GlobeNewswire Inc. - 8/7/2019 6:12:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/6/2019 8:14:23 AM
lumpy9200 Member Level  Saturday, 10/12/19 11:52:26 PM
Re: dhbuzz post# 1999
Post # of 2194 
Hey dh,

I'm still here, long as ever. Been working crazy hours, and haven't had much time for the boards lately. Still reading all posts though. I've been wanting to add more down here, but just havent been able to as I added too much earlier. I remain very confident in the long term, even if it can't seem to break out in the short term. The stock so often gets lumped in with cannabis/CBD companies, and I'm assuming that the total meltdown in that sector has hurt ZYNE. The day it broke $8.00 (to the upside, after first falling into the high $6's a few days before) I really thought it would keep going up and break $10 within a week or two. But then seemingly every cannabis company has gotten destroyed. I've never thought ZYNE should be compared to cannabis and CBD stocks, but not much I can do about it lol. I still think Fragile X is going to be huge for this company. Yes, there's the company Leonard wrote about, but I like ZYNE's chances here. Whoever is first to market will have a huge advantage, along with whichever one has a better safety profile (assuming both get approved). My money remains on ZYNE being first, best and safest. Time will tell....

Best to you and all ZYNE longs

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist